Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/26/2852750/37414/en/Panbela-Provides-Business-Update-and-Reports-Q4-and-FY-2024-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/12/2845035/37414/en/Panbela-to-Host-Fourth-Quarter-and-Year-End-2023-Earnings-Conference-Call-on-March-26-2024.html
https://www.globenewswire.com//news-release/2024/02/15/2829915/37414/en/Panbela-Regains-Compliance-with-Nasdaq-Listing-Standards-for-Bid-Price-and-Publicly-Held-Shares-Requirements.html
https://www.globenewswire.com//news-release/2024/02/01/2821839/37414/en/Panbela-Announces-Closing-of-Approximately-9-0-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/01/30/2819984/37414/en/Acceptance-of-Ivospemin-SBP-101-Abstract-for-Poster-Presentation-at-American-Association-for-Cancer-Research-AACR.html
https://panbela.com/wp-content/uploads/2024/01/PBLA-PR-Offering-2024-01-29.pdf
https://www.globenewswire.com//news-release/2024/01/25/2816570/37414/en/Panbela-Exceeds-50-Enrollment-for-Aspire-Trial-in-Pancreatic-Cancer-Exceeding-Anticipated-Timelines-with-Accelerated-Momentum.html
https://www.globenewswire.com//news-release/2024/01/18/2811519/37414/en/Panbela-Announces-Publication-of-Clinical-Data-Titled-Phase-1-study-of-high-dose-DFMO-celecoxib-cyclophosphamide-and-topotecan-for-patients-with-relapsed-neuroblastoma-A-New-Approa.html
https://www.globenewswire.com//news-release/2024/01/16/2809830/37414/en/Panbela-Announces-1-for-20-Reverse-Stock-Split-Effective-January-18-2024.html
https://www.globenewswire.com//news-release/2023/12/21/2800075/37414/en/Panbela-Therapeutics-Announces-Exercise-of-Warrants-and-Issuance-of-New-Warrants-in-a-Private-Placement-for-2-0-Million-Gross-Proceeds-Priced-At-the-Market.html